CLR-200 series (Clera)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameCLR-200 series (Clera)
Drug Alias Namedopamine D2 partial agonist/D1 agonist (Clera)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor agonistsDopamine D2 receptor partial agonists
TargetsDopamine D1 receptorDopamine D2 receptor
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesClera Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesClera Inc
Active IndicationsN/A
Inactive IndicationsDepression

Other Information

ATC CodeN/A
Related LinksN/A